Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Boehringer Ingelheim
Merck
Moodys
Express Scripts

Last Updated: December 7, 2022

Warfarin sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for warfarin sodium and what is the scope of freedom to operate?

Warfarin sodium is the generic ingredient in five branded drugs marketed by Bristol Myers Squibb, Pharm Res Assoc, Upsher Smith Labs, Abbott, Amneal Pharms, Barr, Chartwell Rx, Invagen Pharms, Ipca Labs Ltd, Mylan, Pliva, Taro, Usl Pharma, Watson Labs, and Zydus Pharms Usa, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for warfarin sodium. Twenty-one suppliers are listed for this compound.

Drug Prices for warfarin sodium

See drug prices for warfarin sodium

Drug Sales Revenue Trends for warfarin sodium

See drug sales revenues for warfarin sodium

Recent Clinical Trials for warfarin sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1
Hospital Israelita Albert EinsteinPhase 4
Industria FarmacĂȘutica Health MedsPhase 4

See all warfarin sodium clinical trials

Pharmacology for warfarin sodium
Drug ClassVitamin K Antagonist
Mechanism of Action Vitamin K Inhibitors

US Patents and Regulatory Information for warfarin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro WARFARIN SODIUM warfarin sodium TABLET;ORAL 040301-003 Jul 15, 1999 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan WARFARIN SODIUM warfarin sodium TABLET;ORAL 040415-004 Sep 27, 2004 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chartwell Rx WARFARIN SODIUM warfarin sodium TABLET;ORAL 040196-004 Sep 30, 1997 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chartwell Rx WARFARIN SODIUM warfarin sodium TABLET;ORAL 040196-005 Sep 30, 1997 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chartwell Rx WARFARIN SODIUM warfarin sodium TABLET;ORAL 040196-008 Jul 26, 2000 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Johnson and Johnson
Express Scripts
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.